Skip to main content
Premium Trial:

Request an Annual Quote

Discussing Decode

It was a confluence of technology, timing, and the economy that led to Decode Genetics' filing for bankruptcy last, says this Nature News post-mortem. The article also warns that personal genomics companies, like Decode's DecodeMe, may also be in trouble as the "services are not seen as a medical necessity." At his blog, Misha Angrist adds what Daniel MacArthur characterizes as "a very brief but eloquent rant." Angrist says the Nature News article is "still trotting out the same tired tropes." He adds: "Just because something is not a medical necessity, does it follow that it is worthless?"

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.